Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 057634/0348 | |
| Pages: | 3 |
| | Recorded: | 09/29/2021 | | |
Attorney Dkt #: | 60118-US-PCT/D2018-40 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17433772
|
Filing Dt:
|
08/25/2021
|
Publication #:
|
|
Pub Dt:
|
05/12/2022
| | | | |
Title:
|
PEGYLATED BILIRUBIN FOR THE TREATMENT OF HYPERLIPIDEMIA, OBESITY, FATTY LIVER DISEASE, CARDIOVASCULAR DISEASES AND TYPE II DIABETES
|
|
Assignee
|
|
|
2801 W. BANCROFT STREET |
TOLEDO, OHIO 43606 |
|
Correspondence name and address
|
|
MACMILLAN, SOBANSKI & TODD, LLC
|
|
720 WATER STREET
|
|
ONE MARITIME PLAZA, FIFTH FLOOR
|
|
TOLEDO, OH 43604
|
Search Results as of:
05/28/2024 05:33 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|